RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
Mikami, Masamitsu, Masuda, Tatsuya, Kanatani, Takuya, Noura, Mina, Umeda, Katsutsugu, Hiramatsu, Hidefumi, Kubota, Hirohito, Daifu, Tomoo, Iwai, Atsushi, Hattori, Etsuko Yamamoto, Furuichi, Kana, Takasaki, Saho, Tanaka, Sunao, Matsui, Yasuzumi, Matsuo, Hidemasa, Hirata, Masahiro, Kataoka, Tatsuki R, Nakahata, Tatsutoshi, Kuwahara, Yasumichi, Iehara, Tomoko, Hosoi, Hajime, Imai, Yoichi, Takita, Junko, Sugiyama, Hiroshi, Adachi, Souichi, Kamikubo, Yasuhiko
Published in Molecules and cells (31.12.2022)
Published in Molecules and cells (31.12.2022)
Get full text
Journal Article
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors
Masamitsu, Mikami, Tatsuya, Masuda, Takuya, Kanatani, Mina, Noura, Katsutsugu, Umeda, Hidefumi, Hiramatsu, Hirohito, Kubota, Tomoo, Daifu, Atsushi, Iwai, Etsuko Yamamoto, Hattori, Kana, Furuichi, Saho, Takasaki, Sunao, Tanaka, Yasuzumi, Matsui, Hidemasa, Matsuo, Masahiro, Hirata, Tatsuki R., Kataoka, Tatsutoshi, Nakahata, Yasumichi, Kuwahara, Tomoko, Iehara, Hajime, Hosoi, Yoichi, Imai, Junko, Takita, Hiroshi, Sugiyama, Souichi, Adachi, Yasuhiko, Kamikubo
Published in Molecules and cells (2022)
Get full text
Published in Molecules and cells (2022)
Journal Article